Zu "1787294-07-8" wurden 2 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
Remibrutinib
Remibrutinib

Artikelnummer: Cay44962-10

Remibrutinib is a covalent inhibitor of Bruton's tyrosine kinase (BTK. IC50 = 1. nM). It selectively binds to BTK over bone marrow tyrosine kinase on chromosome X (BMX) and Tec (Kds = 0. 540, and 110 nM, respectively), as well as IL-2-inducible T cell kinase (Itk), EGFR, HER2, HER4, and JAK3 (Kds = >10,000 nM for...
Schlagworte: LOU064,...
Anwendung: BTK inhibitor
CAS 1787294-07-8
MW: 507.54 D
ab 93,00 €
Bewerten
Remibrutinib
Remibrutinib

Artikelnummer: TGM-T16730-100mg

Description: Remibrutinib inhibits BTK activity with an IC50 value of 0.023 µM in blood. Remibrutinib is an effective and orally active Bruton tyrosine kinase inhibitor (IC50: 1 nM). Remibrutinib has the potential for Chronic urticaria (CU) treatment. Target: BTK. Smiles:...
Anwendung: Targets Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2] (BTK)
CAS 1787294-07-8
MW: 507.53 D
ab 93,00 €
Bewerten